Interestingly, the authors of the meta-analysis showing that therapies directed against IL-6 signalling reduce mortality in patients hospitalised with COVID-19 (16) also concluded that combination treatment strategies may be more effective at inhibiting the inflammatory response than monotherapy. Here, IL6 is linked to COVID-19.